|
🐜
|
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
32 auth.
B. Druker,
F. Guilhot,
S. O’Brien,
I. Gathmann,
H. Kantarjian,
N. Gattermann,
M. Deininger,
R. Silver,
J. Goldman,
R. Stone,
F. Cervantes,
A. Hochhaus,
B. Powell,
J. Gabrilove,
P. Rousselot,
...
J. Reiffers,
J. Cornelissen,
T. Hughes,
H. Agis,
T. Fischer,
G. Verhoef,
J. Shepherd,
G. Saglio,
A. Gratwohl,
J. L. Nielsen,
J. Radich,
B. Simonsson,
K. Taylor,
M. Baccarani,
Charlene So,
L. Letvak,
R. Larson
|
11 |
2006 |
11
🐜
|
|
🐜
|
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
19 auth.
P. Fenaux,
G. Mufti,
E. Hellstrom-Lindberg,
V. Santini,
C. Finelli,
A. Giagounidis,
R. Schoch,
N. Gattermann,
G. Sanz,
A. List,
...
S. Gore,
J. Seymour,
J. Bennett,
J. Byrd,
J. Backstrom,
L. Zimmerman,
D. McKenzie,
C. Beach,
L. Silverman
|
11 |
2009 |
11
🐜
|
|
🐜
|
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia.
16 auth.
P. Fenaux,
G. Mufti,
E. Hellström-Lindberg,
V. Santini,
N. Gattermann,
U. Germing,
G. Sanz,
A. List,
S. Gore,
J. Seymour,
...
H. Dombret,
J. Backstrom,
L. Zimmerman,
D. McKenzie,
C. L. Beach,
L. Silverman
|
9 |
2010 |
9
🐜
|
|
🐜
|
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.
18 auth.
H. Kantarjian,
F. Giles,
N. Gattermann,
K. Bhalla,
G. Alimena,
F. Palandri,
G. Ossenkoppele,
F. Nicolini,
S. O’Brien,
M. Litzow,
...
R. Bhatia,
F. Cervantes,
A. Haque,
Y. Shou,
D. Resta,
A. Weitzman,
A. Hochhaus,
P. le Coutre
|
9 |
2007 |
9
🐜
|
|
🐜
|
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
22 auth.
L. Malcovati,
E. Hellström-Lindberg,
D. Bowen,
L. Adès,
J. Čermák,
C. del Cañizo,
M. D. Della Porta,
P. Fenaux,
N. Gattermann,
U. Germing,
...
J. Jansen,
M. Mittelman,
G. Mufti,
U. Platzbecker,
G. Sanz,
D. Selleslag,
Mette Skov-Holm,
R. Stauder,
A. Symeonidis,
A. A. van de Loosdrecht,
T. D. de Witte,
M. Cazzola
|
9 |
2013 |
9
🐜
|
|
🐜
|
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
80 auth.
E. Bernard,
Y. Nannya,
R. Hasserjian,
S. Devlin,
H. Tuechler,
J. Medina-Martinez,
T. Yoshizato,
Y. Shiozawa,
R. Saiki,
L. Malcovati,
M. Levine,
Juan E. Arango,
Yangyu Zhou,
F. Solé,
C. Cargo,
...
D. Haase,
M. Creignou,
U. Germing,
Yanming Zhang,
G. Gundem,
Araxe Sarian,
A. A. van de Loosdrecht,
M. Jädersten,
M. Tobiasson,
O. Kosmider,
M. Follo,
F. Thol,
R. Pinheiro,
V. Santini,
I. Kotsianidis,
J. Boultwood,
F. P. Santos,
J. Schanz,
S. Kasahara,
T. Ishikawa,
H. Tsurumi,
A. Takaori-Kondo,
T. Kiguchi,
C. Polprasert,
J. Bennett,
V. Klimek,
M. Savona,
M. Belickova,
C. Ganster,
L. Palomo,
G. Sanz,
L. Adès,
M. D. Della Porta,
Harold Elias,
Alexandra G. Smith,
Yesenia Werner,
Minal A. Patel,
A. Viale,
K. Vanness,
D. Neuberg,
K. Stevenson,
K. Menghrajani,
K. Bolton,
P. Fenaux,
A. Pellagatti,
U. Platzbecker,
M. Heuser,
P. Valent,
S. Chiba,
Y. Miyazaki,
C. Finelli,
M. Voso,
L. Shih,
M. Fontenay,
J. Jansen,
J. Cervera,
Y. Atsuta,
N. Gattermann,
B. Ebert,
R. Bejar,
P. Greenberg,
M. Cazzola,
E. Hellström-Lindberg,
S. Ogawa,
E. Papaemmanuil
|
8 |
2019 |
8
🐜
|
|
🐜
|
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.
21 auth.
R. Levine,
M. Loriaux,
B. Huntly,
M. Loh,
M. Beran,
E. Stoffregen,
R. Berger,
Jennifer J. Clark,
S. Willis,
Kim T. Nguyen,
...
N. J. Flores,
E. Estey,
N. Gattermann,
S. Armstrong,
A. Look,
J. Griffin,
O. Bernard,
M. Heinrich,
D. Gilliland,
B. Druker,
M. Deininger
|
8 |
2005 |
8
🐜
|
|
🐜
|
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results.
19 auth.
H. Kantarjian,
F. Giles,
K. Bhalla,
J. Pinilla-Ibarz,
R. Larson,
N. Gattermann,
O. Ottmann,
A. Hochhaus,
J. Radich,
G. Saglio,
...
T. Hughes,
G. Martinelli,
Dong-Wook Kim,
Y. Shou,
N. Gallagher,
R. Blakesley,
M. Baccarani,
J. Cortes,
P. le Coutre
|
8 |
2011 |
8
🐜
|
|
🐬
|
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients.
U. Germing,
N. Gattermann,
C. Strupp,
M. Aivado,
C. Aul
|
8 |
2000 |
8
🐬
|
|
🐜
|
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
19 auth.
M. Cappellini,
J. Porter,
A. El‐Beshlawy,
Chi-kong Li,
J. Seymour,
Mohsen Saleh Elalfy,
N. Gattermann,
S. Giraudier,
Jong-Wook Lee,
L. Chan,
...
K. Lin,
C. Rose,
A. Taher,
S. Thein,
V. Viprakasit,
D. Habr,
G. Domokos,
B. Roubert,
A. Kattamis
|
8 |
2010 |
8
🐜
|
|
🐜
|
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.
23 auth.
P. le Coutre,
O. Ottmann,
F. Giles,
Dong-Wook Kim,
J. Cortes,
N. Gattermann,
J. Apperley,
R. Larson,
E. Abruzzese,
S. O’Brien,
...
K. Kuliczkowski,
A. Hochhaus,
F. Mahon,
G. Saglio,
M. Gobbi,
Y. Kwong,
M. Baccarani,
T. Hughes,
G. Martinelli,
J. Radich,
M. Zheng,
Y. Shou,
H. Kantarjian
|
8 |
2008 |
8
🐜
|
|
🐜
|
[Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction].
8 auth.
B. Strauer,
M. Brehm,
T. Zeus,
N. Gattermann,
Adrian F. Hernandez,
R. Sorg,
...
G. Kögler,
P. Wernet
|
8 |
2001 |
8
🐜
|
|
🐜
|
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study
30 auth.
J. Porter,
R. Galanello,
G. Saglio,
E. Neufeld,
E. Vichinsky,
M. Cappellini,
N. Olivieri,
A. Piga,
Melody J. Cunningham,
D. Soulières,
N. Gattermann,
G. Tchernia,
J. Maertens,
P. Giardina,
J. Kwiatkowski,
...
G. Quarta,
M. Jeng,
G. Forni,
M. Stadler,
H. Cario,
L. Debusscher,
M. D. Porta,
M. Cazzola,
P. Greenberg,
G. Alimena,
B. Rabault,
I. Gathmann,
J. Ford,
D. Alberti,
C. Rose
|
8 |
2007 |
8
🐜
|
